Vir Biotechnology Inc (VIR) — Working Capital to Net Assets Ratio
Vir Biotechnology Inc (VIR) has a Working Capital to Net Assets ratio of 48.7% as of June 2026. Working capital of $478.78 Million (current assets of $573.74 Million minus current liabilities of $94.96 Million) is measured against net assets of $982.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Vir Biotechnology Inc (VIR) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Vir Biotechnology Inc Working Capital to Net Assets (2017–2025)
This chart shows how Vir Biotechnology Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 48.7%, reflecting working capital of $478.78 Million against net assets of $982.49 Million USD. For the complete balance sheet picture, see balance sheet size of Vir Biotechnology Inc.
Annual Working Capital to Net Assets for Vir Biotechnology Inc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Vir Biotechnology Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Vir Biotechnology Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 55.0% | $421.26 Million | $765.28 Million | $514.08 Million | $92.81 Million | ▼ -25.2 pp |
| 2024 | 80.2% | $922.80 Million | $1.15 Billion | $1.04 Billion | $119.66 Million | ▼ -8.6 pp |
| 2023 | 88.8% | $1.41 Billion | $1.59 Billion | $1.59 Billion | $175.41 Million | ▼ -7.8 pp |
| 2022 | 96.6% | $2.01 Billion | $2.08 Billion | $2.52 Billion | $511.03 Million | ▲ +11.3 pp |
| 2021 | 85.3% | $1.22 Billion | $1.43 Billion | $1.56 Billion | $341.24 Million | ▼ -8.6 pp |
| 2020 | 93.9% | $673.30 Million | $716.85 Million | $772.37 Million | $99.06 Million | ▲ +12.8 pp |
| 2019 | 81.1% | $343.79 Million | $423.94 Million | $403.00 Million | $59.21 Million | ▲ +124.6 pp |
| 2018 | -43.5% | $77.88 Million | $-179.18 Million | $117.78 Million | $39.91 Million | ▲ +217.6 pp |
| 2017 | -261.1% | $179.91 Million | $-68.92 Million | $192.35 Million | $12.44 Million | — |